DOCSLIB.ORG

Esophagogastric Tamponade Tube

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Esophagogastric Tamponade Tube Unit IV Gastrointestinal System Section Sixteen Special Gastrointestinal Procedures PROCEDURE Esophagogastric 108 Tamponade Tube Rosemary Lee PURPOSE: Esophagogastric tamponade therapy is used to provide temporary control of bleeding from gastric or esophageal varices. • Contraindications include latex allergy, esophageal strictures, PREREQUISITE NURSING and recent esophageal surgery. Relative contraindications are KNOWLEDGE heart failure, respiratory failure, hiatal hernia, severe pulmo- nary hypertension, and cardiac dysrhythmias. 4,8,12 • Tamponade therapy exerts direct pressure against the • Because of the risk for aspiration, it is recommended the varices with the use of a gastric and/or esophageal balloon patient be endotracheally intubated for airway protection and may be used for patients who are unresponsive to before esophagogastric tamponade tube insertion. 13 medical therapy or are too hemodynamically unstable for • Sedation should be considered, but dosing should be indi- endoscopy or sclerotherapy. 1,3 vidualized on the assessment of each patient. Sedation • Esophagogastric tamponade tubes are used to control should be used with caution in the setting of liver injury bleeding from either gastric and/or esophageal varices. and/or failure due to these patients ’ impaired metabolism The suction lumens allow the evacuation of accumulated of sedating medications. The plan for sedation, if needed, blood from the stomach or esophagus. The suction lumens is individualized with the goal to achieve patient comfort. also allow for the intermittent instillation of saline solu- • Head of bed (HOB) should be at least 30 to 45 degrees at tion to assist with evacuation of blood or clots and provide all times to reduce the risk of aspiration. 6 a means of irrigation if indicated. • The use of esophageal tamponade is decreasing in clinical • Three types of tubes are available for esophagogastric practice because up to 50% of varices rebleed after the tamponade therapy. The two most common tubes are the balloons are defl ated. 12,13 Additionally, major complica- Sengstaken-Blakemore (Bard, Inc., Covington, Georgia) tions can occur with the use of esophageal balloon tam- tube ( Fig. 108-1 ) and the Minnesota esophagogastric tam- ponade therapy. 13 However, esophagogastric tubes are still ponade tube. The Sengstaken-Blakemore tube has a used in areas where esophagogastric duodenoscopy is not gastric and esophageal balloon and a gastric aspiration readily available. The use of esophageal tamponade is lumen. The four-lumen Minnesota tube ( Fig. 108-2 ) has designed to be a temporary intervention until more defi ni- gastric and esophageal balloons and separate gastric and tive therapy can be carried out. Balloon tamponade is esophageal aspiration lumens. The third, the Linton or recommended to be used for only 24 to 48 hours. 2,13 Linton-Nachlas tube, (Mallinckrodt Inc., Tyco Health Care Group, Hampshire, UK) has a gastric balloon and EQUIPMENT separate gastric and esophageal aspiration lumens and is used only for treatment of bleeding gastric varices. The • Tamponade tube (Sengstaken-Blakemore, Minnesota, or Minnesota tube is considered the preferred tube for esoph- Linton-Nachlas) agogastric tamponade therapy because it allows for aspi- • Irrigation kit (or catheter-tip, 60-mL syringe and basin) ration of drainage above the esophageal balloon and • Nasogastric (NG) tubes (one for Sengstaken-Blakemore below the gastric balloon. tube) • Esophagogastric tamponade tubes may be introduced via • Normal saline (NS) solution for irrigation either the nasogastric or the orogastric route. The tubes • Water-soluble lubricant are then advanced through the oropharynx and esophagus • Topical anesthetic agent and into the stomach. • Sphygmomanometer or pressure gauge 958 108 Esophagogastric Tamponade Tube 959 Esophageal balloon Gastric Esophageal aspiration balloon Gastric balloon Figure 108-3 Balanced suspension traction securing tamponade tube and placement. (From DeGroot KD, Damato M: Critical care skills, Norwalk, CT, 1987, Appleton & Lange.) Gastric balloon Football helmet Face guard Esophageal Figure 108-1 Sengstaken-Blakemore tube in place with both the balloon inflation port esophageal and gastric balloons infl ated. (From Carlson KK, editor: Philadelphia, 2009, Saunders.) AACN advanced critical care nursing, Gastric aspiration port Chin strap Gastric balloon inflation port Gastric aspirate Figure 108-4 Tamponade tube secured in position with helmet. Esophageal aspirate Gastric balloon Esophageal balloon • Four rubber-shod clamps or plastic plugs that may come with the balloon kit • Adhesive tape Esophageal balloon • Two suction setups and tubing • Cardiac monitor • Scissors, must be kept at bedside Gastric balloon Additional equipment, to have available as needed, includes the following: • Rubber cube sponge (used for nasal tamponade tube Figure 108-2 Minnesota four-lumen tube. (From Swearingen placement)—may be used for traction PL: Photo atlas of nursing procedures, Reading, MA, 1991, • Balanced suspension traction apparatus with 1 pound of Addison-Wesley.) weights, 500 mL of NS solution ( Fig. 108-3 ), or football helmet with face mask ( Fig. 108-4 ) 960 Unit IV Gastrointestinal System ❖ Decreased hematocrit and hemoglobin values ❖ Change in level of consciousness • Assess the baseline cardiac rhythm. Rationale: Passage of a large-bore tube into the esophagus may cause vagal stimulation and bradycardia. • Assess the baseline respiratory status (i.e., rate, depth, pattern, and characteristics of secretions). Rationale: Use of topical anesthetic agents in the nares or oropharynx may alter the gag or cough refl ex, increasing the risk for aspiration. Passage of a large-bore tube may impair the airway. Large amounts of blood in the stomach predispose a patient to vomiting and potential aspiration. Figure 108-5 Lopez valve. (Courtesy of ICU Medical, Inc,. San • Assess the patient ’ s ability to protect the airway. Ratio- Clemente, CA.) nale: Multiple factors can infl uence the patient ’ s ability to protect the airway, including the presence of vomiting and depressed mental status. Inserting an endotracheal • Lopez enteral valve ( Fig. 108-5 ) (ICU Medical, San Cle- tube before inserting the esophageal balloon is mente, CA), a three-way stopcock used to attach a 60-mL recommended. 13 catheter-tip syringe and the handheld manometer to the • Assess the patient ’ s level of consciousness. Rationale: If Minnesota tube the patient has an altered level of consciousness, he or she • Emergency medications and equipment, including trans- may need to be intubated and mechanically ventilated cutaneous pacemaker and intubation equipment prophylactically to prevent airway complications. • Endotracheal suction equipment • If anticipating a nasal esophageal tube placement: • Marker ❖ Assess for medical history of nasal deformity, surgery, • Cervical collar trauma, epistaxis, or coagulopathy. Rationale: The risk for complications and bleeding with nasal insertion is PATIENT AND FAMILY EDUCATION increased. ❖ Evaluate patency of nares. Occlude one naris at a time, • Explain the procedure and reason for the esophagogas- and ask the patient to breathe through the nose. Select tric tube insertion. Rationale: Patient anxiety may be the naris with the best airfl ow. Rationale: Choosing the decreased. most patent naris eases insertion and may improve • Explain the patient ’ s role (if applicable) in assisting with patient tolerance of the tube. the passage of the tube and maintenance of tamponade ❖ The nasal route is not recommended in patients with traction. Rationale: Patient cooperation is elicited during coagulopathy. Rationale: The risk for bleeding and the insertion and tamponade therapy. complications is increased. • Explain to the patient that the procedure may be uncom- • Assess for allergy to latex. Rationale: Balloon tamponade fortable because the gag refl ex may be stimulated, causing tubes contain natural latex and may cause anaphylaxis in the patient to be nauseated or to vomit. Rationale: This patients with a latex allergy. explanation prepares the patient for what to expect during the procedure. Patient Preparation • Ensure that the patient and family understand preproce- dural information. Answer questions as they arise, and PATIENT ASSESSMENT AND reinforce information as needed. Rationale: Understand- PREPARATION ing of previously taught information is evaluated and rein- forced. Typically this is an emergency procedure and the Patient Assessment patient and family will be under stress. • Assess signs and symptoms of major blood loss. Ratio- • The physician, advanced practice nurse, or other health- nale: Esophageal or gastric varices can cause signifi cant care professional measures the tube from the bridge of the blood loss: nose to the earlobe to the tip of the xiphoid process. Mark ❖ Tachycardia the length of tube to be inserted. Rationale: Estimating ❖ Tachypnea the length of tube to be inserted helps place the distal tip ❖ Hypotension in the stomach. ❖ Decreased urine output • If the patient is alert, elevate the patient ’ s HOB to 30 to ❖ Decreased fi lling pressures (pulmonary artery pressure, 45 degrees. If the patient is unconscious or obtunded, pulmonary artery wedge pressure, central venous pres- place the patient ’ s head down in the left lateral position. sure, stroke volume, stroke volume index) Rationale: Positioning facilitates the passage of the tube ❖ Decreased platelet counts into the stomach and reduces the risk for aspiration.
Load more

Recommended publications
  • Letters to the Editor
    letters to the Editor Porphyria, Cardiopulmonary Bypass, and heart with additional hemorrhage into the pericardial sac (5). Peri- cardiocentesis, however, can be a temporizing measure in the se- Volatile Anesthetics verely compromised patient (4,7,8) until definitive surgical estab- lishment of a pericardial window. A pericardial window can be To the Editor: established under local anesthesia (9) via the subxiphoid or lateral We take issue with Stevens et al’s contentious statements in their thoracotomy approach (1,2,5,8,9). The subxiphoid approach is less discussion of volatile anesthetics in the patient with acute intermit- useful for trauma because limited surgical exposure may preclude tent porphyria undergoing mitral valve replacement (1). repair of cardiac wounds (2). However, a pericardial window dur- In the “pre-propofol” era, the safe and appropriate use of halo- ing awake lateral thoracotomy may be both poorly tolerated and thane and isoflurane in porphyric patients was established (2). dangerous in the distressed, moving patient (7). Recent reports of the successful use of isoflurane in porphyric A blunt trauma victim (2) recently presented for an emergent patients undergoing cardiac surgery also exist (3,4). As the authors surgical pericardial window for recurrent acute pericardial tampon- themselves allude to a report of elevated porphyrins after propofol ade. Although the patient was not hypotensive, jugular venous anesthesia in acute intermittent porphyria, favoring propofol over distention, pulsus paradoxus (1,3,7), patient distress (4), and echo- inhaled anesthetics because of the latter’s implied lack of a “safety cardiographic signs were present. As an alternative to endotracheal record” cannot be supported.
    [Show full text]
  • Incidence, Risk Factors and Management of Severe Post-Transsphenoidal Epistaxis Q ⇑ Kenneth M
    Journal of Clinical Neuroscience 22 (2015) 116–122 Contents lists available at ScienceDirect Journal of Clinical Neuroscience journal homepage: www.elsevier.com/locate/jocn Clinical Study Incidence, risk factors and management of severe post-transsphenoidal epistaxis q ⇑ Kenneth M. De Los Reyes a, Bradley A. Gross a, , Kai U. Frerichs a, Ian F. Dunn a, Ning Lin a, Jordina Rincon-Torroella a, Donald J. Annino b, Edward R. Laws a a Department of Neurological Surgery, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA b Department of Otolaryngology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA article info abstract Article history: Among the major complications of transsphenoidal surgery, less attention has been given to severe post- Received 16 June 2014 operative epistaxis, which can lead to devastating consequences. In this study, we reviewed 551 consec- Accepted 2 July 2014 utive patients treated over a 4 year period by the senior author to evaluate the incidence, risk factors, etiology and management of immediate and delayed post-transsphenoidal epistaxis. Eighteen patients (3.3%) developed significant postoperative epistaxis – six immediately and 12 delayed (mean postoper- Keywords: ative day 10.8). Fourteen patients harbored macroadenomas (78%) and 11 of 18 (61.1%) had complex Endoscopic nasal/sphenoid anatomy. In the immediate epistaxis group, 33% had acute postoperative hypertension. Epistaxis In the delayed group, one had an anterior ethmoidal pseudoaneurysm, and one had restarted anticoagu- Management Microscopic lation on postoperative day 3. We treated the immediate epistaxis group with bedside nasal packing fol- Pituitary lowed by operative re-exploration if conservative measures were unsuccessful.
    [Show full text]
  • World Journal of Hepatology
    World Journal of W J H Hepatology Submit a Manuscript: https://www.f6publishing.com World J Hepatol 2020 June 27; 12(6): 288-297 DOI: 10.4254/wjh.v12.i6.288 ISSN 1948-5182 (online) ORIGINAL ARTICLE Retrospective Cohort Study Hospital teaching status on the outcomes of patients with esophageal variceal bleeding in the United States Pavan Patel, Laura Rotundo, Evan Orosz, Faiz Afridi, Nikolaos Pyrsopoulos ORCID number: Pavan Patel Pavan Patel, Faiz Afridi, Nikolaos Pyrsopoulos, Division of Gastroenterology and Hepatology, (0000-0001-5682-4939); Laura Rutgers - New Jersey Medical School, Newark, NJ 07101-1709, United States Rotundo (0000-0002-4094-3682); Evan Orosz (0000-0003-2474-5501); Laura Rotundo, Evan Orosz, Department of Medicine, Rutgers - New Jersey Medical School, Faiz Afridi (0000-0002-0172-0486); Newark, NJ 07101-1709, United States Nikolaos Pyrsopoulos (0000-0002-6950-8174). Corresponding author: Nikolaos Pyrsopoulos, FACP, MD, PhD, Chief Doctor, Professor, Division of Gastroenterology and Hepatology, Rutgers – New Jersey Medical School, 185 S. Author contributions: Patel P Orange Avenue, MSB H-535, Newark, NJ 07101-1709, United States. provided conception and design of [email protected] the study, acquisition and analysis of data, and drafting of the manuscript; Rotundo L, Afridi F and Orosz E drafted the manuscript; Pyrsopoulos N Abstract contributed to the manuscript by BACKGROUND providing revision and oversight Acute variceal bleeding is a major complication of portal hypertension and is a of its writing. leading cause of death in patients with cirrhosis. There is limited data on the Institutional review board outcomes of patients with esophageal variceal bleeding in teaching versus statement: This study did not nonteaching hospitals.
    [Show full text]
  • Femoral and Sciatic Nerve Blocks for Total Knee Replacement in an Obese Patient with a Previous History of Failed Endotracheal Intubation −A Case Report−
    Anesth Pain Med 2011; 6: 270～274 ￭Case Report￭ Femoral and sciatic nerve blocks for total knee replacement in an obese patient with a previous history of failed endotracheal intubation −A case report− Department of Anesthesiology and Pain Medicine, School of Medicine, Catholic University of Daegu, Daegu, Korea Jong Hae Kim, Woon Seok Roh, Jin Yong Jung, Seok Young Song, Jung Eun Kim, and Baek Jin Kim Peripheral nerve block has frequently been used as an alternative are situations in which spinal or epidural anesthesia cannot be to epidural analgesia for postoperative pain control in patients conducted, such as coagulation disturbances, sepsis, local undergoing total knee replacement. However, there are few reports infection, immune deficiency, severe spinal deformity, severe demonstrating that the combination of femoral and sciatic nerve blocks (FSNBs) can provide adequate analgesia and muscle decompensated hypovolemia and shock. Moreover, factors relaxation during total knee replacement. We experienced a case associated with technically difficult neuraxial blocks influence of successful FSNBs for a total knee replacement in a 66 year-old the anesthesiologist’s decision to perform the procedure [1]. In female patient who had a previous cancelled surgery due to a failed tracheal intubation followed by a difficult mask ventilation for 50 these cases, peripheral nerve block can provide a good solution minutes, 3 days before these blocks. FSNBs were performed with for operations on a lower extremity. The combination of 50 ml of 1.5% mepivacaine because she had conditions precluding femoral and sciatic nerve blocks (FSNBs) has frequently been neuraxial blocks including a long distance from the skin to the used for postoperative pain control after total knee replacement epidural space related to a high body mass index and nonpalpable lumbar spinous processes.
    [Show full text]
  • Transaction Code Description
    Transaction Code Description Price KIT ACCESSORY BOOT/ANCHOR 0.00 AMPUTATIONS-SUPPL 0.00 PRESSURE MONITOR SWAN KIT 0.00 LVAD DRIVE LINE KIT 0.00 OXYGEN 0.00 NU-GAUZE,IODAFRM 1INCH 0.00 ARTHROTMY-SUPPL 0.00 BONE & OTHER-SUPPL 0.00 DRUG TEST-DEFINITIVE 1-7 0.00 RESTRAINTS,WRST-LMB 0.00 FEM-POPLIT.BYP-SUPPL 0.00 SORENSON MONITOR KIT 0.00 SUPPLEMENTAL NURSING SYS 0.00 BONE ACCESS KIT 0.00 PERFUSION CUSTOM PACK 0.00 PICC DRESSING CHANGE KIT 0.00 FOLLOLWUP 30 0.00 KIT PORTICO DELIVERY SYST 0.00 PACK,NASAL POST W/DRAWSTR 0.00 PLASTIC RECONS-SUPPL 0.00 COOL CATH TUBING KIT 0.00 CARDIAC ANESTHESIA SUPPLY 0.00 PORT-A-CATH-SUPPL 0.00 CARDINAL PAIN INJ KIT 0.00 BIOPSY TRAY 0.00 KIT(LF)ENDOSCOPIC VASVIEW 0.00 MRI CHEST W/CONTRAST 0.00 PCK CARDIAC HEART STERILE 0.00 POWER PULSE KIT 0.00 LEFT HEART CUSTOM KIT 0.00 M & T-SUPPL 0.00 HIP NAILING-SUPPL 0.00 PULSE LAVAGE KIT 0.00 GASTROSTOMY KIT 0.00 LEEP KIT 0.00 DRUG TEST-DEFINITIVE 8-14 0.00 BOTTLE WATER 1.5L 0.00 TEMP WIRE W/INTRODUCERKIT 0.00 SUPPORTER,A3 ADULT-M 0.00 I & D'S-SUPPL 0.00 CRANIOTOMY-SUPPL 0.00 POUCH FLEX MAXI UROSTOMY 0.00 GOOD GRIP SPOON 0.00 OXYHOOD 12- 0.00 SPINAL CARE KIT JACKSON 0.00 BI&UNILAT VEIN-SUPPL 0.00 DRUG TEST-DEFINITIVE15-21 0.00 CUDDLECUP INSERT 0.00 BLANKET (LF) BAIR HUGGER UPPER BODY 0.00 MASTECTOMY-SUPPL 0.00 LOA RMU 0.00 PACK LINQ 0.00 CHOLECYSTECTOM-SUPPL 0.00 RES BWL,SIG,AP-SUPPL 0.00 TRAY BIOPSY GENERAL UTIL 0.00 KIT(LF)CUSTOM SYRINGE ANGIO 0.00 OXISENSOR(LF)PEDI (PINK) 0.00 THORACIC SURG-SUPPL 0.00 NU-GAUZE PLAIN 1/2INCH 0.00 NU-GAUZE,IODAFRM 1/4INCH 0.00 PICC
    [Show full text]
  • Progressive Mandibular Midline Deviation After Difficult Tracheal
    Anaesthesia 2013 doi:10.1111/anae.12271 Case Report Progressive mandibular midline deviation after difficult tracheal intubation J. Mareque Bueno,1,2 M. Fernandez-Barriales,3 M. A. Morey-Mas4,5 and F. Hernandez-Alfaro6,7 1 Associate Professor, 6 Professor, Department of Oral and Maxillofacial Surgery, Universitat Internacional de Catalunya, Barcelona, Spain 2 Staff, 3 Visiting Resident, 7 Director, Institute of Maxillofacial Surgery, Teknon Medical Center, Barcelona, Spain 4 Staff, Department of Oral and Maxillofacial Surgery, Hospital Son Dureta, Palma de Mallorca, Illes Balears, Spain 5 Associate Professor, Especialidad Universitaria en Implantologıa Oral, Universitat des Illes Balears, Illes Balears, Spain Summary We report condylar resorption of the temporomandibular joint after difficult intubation, leading to progressive midline mandibular deviation, subsequently treated by prosthetic joint replacement. ................................................................................................................................................................. Correspondence to: M. Fernandez-Barriales Email: [email protected] Accepted: 19 March 2013 Forces applied during difficult tracheal intubations can Following induction of anaesthesia and neuromus- cause oedema, bleeding, tracheal and oesophageal per- cular blockade, laryngoscopy with a Macintosh blade foration, pneumothorax or aspiration. Resorption of (size 3) permitted revealed a poor laryngeal view the temporomandibular joint has not been associated (Cormack-Lehane
    [Show full text]
  • Chapter I GENERAL CORRECT CODING POLICIES for NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL for MEDICARE SERVICES
    CHAP1-gencorrectcodingpolicies Revision Date: 1/1/2021 Chapter I GENERAL CORRECT CODING POLICIES FOR NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL FOR MEDICARE SERVICES Current Procedural Terminology (CPT) codes, descriptions and other data only are copyright 2020 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association. Applicable FARS\DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors, prospective payment systems, and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for the data contained or not contained herein. Revision Date (Medicare): 1/1/2021 Table of Contents LIST OF ACRONYMS ............................................ I-2 Chapter I ................................................... I-4 General Correct Coding Policies ............................ I-4 A. Introduction ..........................................I-4 B. Coding Based on Standards of Medical/Surgical Practice I-8 C. Medical/Surgical Package .............................I-11 D. Evaluation & Management (E&M) Services ...............I-16 E. Modifiers and Modifier Indicators ....................I-18 F. Standard Preparation/Monitoring Services for Anesthesia .................................................. I-26 G. Anesthesia Service Included in the Surgical Procedure I-26 H. HCPCS/CPT
    [Show full text]
  • Application and Care of Two Kinds of Sphenoid Sinus Packing Materials After Pituitary Tumor Resection with the Transnasal Endoscopic Approach
    Neuroscience & Medicine, 2020, 11, 130-141 https://www.scirp.org/journal/nm ISSN Online: 2158-2947 ISSN Print: 2158-2912 Application and Care of Two Kinds of Sphenoid Sinus Packing Materials after Pituitary Tumor Resection with the Transnasal Endoscopic Approach Shuo Yang, Qiyu Feng, Huidan Zhu, Zhihuan Zhou*, Ji Zhang* Department of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China How to cite this paper: Yang, S., Feng, Abstract Q.Y., Zhu, H.D., Zhou, Z.H. and Zhang, J. (2020) Application and Care of Two Kinds Background: Neuroendoscopic transsphenoidal approach for resection of of Sphenoid Sinus Packing Materials after pituitary adenomas has the advantages of less damage, fewer complications, Pituitary Tumor Resection with the Trans- and a faster recovery than the traditional approach and has beening favored nasal Endoscopic Approach. Neuroscience by neurosurgeons. However, there has no standard method of selecting suita- & Medicine, 11, 130-141. https://doi.org/10.4236/nm.2020.114015 ble packing materials after the operation to relieve pain in patients and achieve the ideal hemostatic effect. We compared the postoperative complica- Received: October 4, 2020 tions and treatment effects of two different packing materials in patients with Accepted: December 12, 2020 pituitary adenomas. Objective: To investigate the advantages and disadvan- Published: December 15, 2020 tages of using a catheter balloon and iodoform gauze for hemostasis in pa- Copyright © 2020 by author(s) and tients undergoing pituitary tumor resection by neuroendoscopic transsphe- Scientific Research Publishing Inc. noidal approach. Materials and Methods: We retrospectively analyzed these This work is licensed under the Creative data of 48 cases treated with pituitary adenoma resection by the single nasal Commons Attribution International License (CC BY 4.0).
    [Show full text]
  • Review Article the Management of Difficult Intubation in Children
    Pediatric Anesthesia 2009 19 (Suppl. 1): 77–87 doi:10.1111/j.1460-9592.2009.03014.x Review article The Management of difficult intubation in children ROBERT W.M. WALKER FRCA* AND JAMES ELLWOOD FRCA† *Department of Paediatric Anaesthesia, Royal Manchester Children’s Hospital, Pendlebury, Manchester and †Department of Paediatric Anaesthesia, Royal Manchester Children’s Hospital, North West School of Anaesthesia, Pendlebury, Manchester Summary This article looks at the current techniques and equipment recom- mended for the management of the difficult intubation scenario in pediatric practice. We discuss the general considerations including preoperative preparation, the preferred anesthetic technique and the use of both rigid laryngoscopic and fiberoptic techniques for intuba- tion. The unanticipated scenario is also discussed. Keywords: paediatric; anaesthesia; difficult airway; difficult intubation; failed intubation; fibreoptic intubation; Laryngeal mask Introduction issues which need to be discussed in detail with the parents and the child if appropriate. This should be Generally, but not always, in pediatric practice, the performed well in advance at the preoperative visit. management of the difficult intubation scenario is a Firstly, the relative benefit of any planned surgery well predicted, well planned and hopefully well must be weighed against the possible risks of the executed procedure. However, undoubtedly, there anesthetic management. If there is any doubt sur- will be occasions when difficulty with either airway rounding either the timing of the surgery or indeed management (difficulty or inability to ventilate the the need for surgery, a full discussion should take patient or maintain an airway) and ⁄ or with endo- place with carers, child, surgeon and anesthetist to tracheal intubation is unexpected.
    [Show full text]
  • Nasal Intubation: a Comprehensive Review
    662 Review Article Nasal intubation: A comprehensive review Varun Chauhan, Gaurav Acharya Nasal intubation technique was first described in 1902 by Kuhn. The others pioneering the Access this article online nasal intubation techniques were Macewen, Rosenberg, Meltzer and Auer, and Elsberg. It Website: www.ijccm.org is the most common method used for giving anesthesia in oral surgeries as it provides a DOI: 10.4103/0972-5229.194013 good field for surgeons to operate. The anatomy behind nasal intubation is necessary to Quick Response Code: Abstract know as it gives an idea about the pathway of the endotracheal tube and complications encountered during nasotracheal intubation. Various techniques can be used to intubate the patient by nasal route and all of them have their own associated complications which are discussed in this article. Various complications may arise while doing nasotracheal intubation but a thorough knowledge of the anatomy and physics behind the procedure can help reduce such complications and manage appropriately. It is important for an anesthesiologist to be well versed with the basics of nasotracheal intubation and advances in the techniques. A thorough knowledge of the anatomy and the advent of newer devices have abolished the negative effect of blindness of the procedure. Keywords: Blind nasal intubation, complications, epistaxis, fiber optic, nasotracheal intubation Introduction (e.g., mandibular reconstructive procedures or mandibular osteotomies) and oropharyngeal surgeries. Nasal intubation technique was first
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Xellia Pharmaceuticals, Aps Advisory Committee Background Document
    BACITRACIN for Injection (bacitracin) Advisory Committee Background Document Staphylococcal pneumonia and empyema in infants Xellia Pharmaceuticals, ApS Advisory Committee Background Document Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC) on Safety and Efficacy of Bacitracin for Intramuscular Injection BACITRACIN for Injection (bacitracin) AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Issue/Report Date: 28 March 2019 Approved date: 27 March 2019 Page 1 of 52 BACITRACIN for Injection (bacitracin) Advisory Committee Background Document Staphylococcal pneumonia and empyema in infants Table of Contents 1 EXECUTIVE SUMMARY ............................................................................................................5 2 Introduction .....................................................................................................................................7 3 Clinical data on effectiveness of bacitracin for injection ................................................................8 3.1 Approved Indication: Staphylococcal Pneumonia and Empyema in Infants ........................... 8 3.1.1 Supporting data on the treatment of lung infections in adults ........................................... 9 3.1.2 Data on intrapleural administration in infants and children with empyema ...................... 9 3.2 Alternate uses for Bacitracin for injection .............................................................................. 10 3.2.1 Surgical Site Infection (SSI) Prophylaxis .......................................................................
    [Show full text]